ESC update: Empagliflozin Cuts risk of Hospitalization, CV Mortality in HFrEF: EMPEROR Hina Zahid29 Aug 2020 11:45 AM ISTSophia Antipolis, France - Empagliflozin is second SGLT2 inhibitor after dapagliflozin to show a significant benefit in the treatment of reduced...
Rare case of Gastrointestinal Myeloid Sarcoma reported in NEJM Dr. Kamal Kant Kohli28 Aug 2020 6:15 PM ISTDr Trisha S. Pasricha and Dr Diane Abraczinskas at Massachusetts General Hospital, Boston, MA have reported a rare case of Gastrointestinal Myeloid...
PCSK9 inhibitor Evinacumab may significantly lower LDL cholesterol in FH: NEJM Medha Baranwal21 Aug 2020 11:30 AM ISTDelhi: Evinacumab significantly lowers LDL cholesterol levels in patients with homozygous familial hypercholesterolemia receiving maximum...
Diet or surgery- It's weight loss that improves blood sugar in diabetes: NEJM study Dr. Kamal Kant Kohli20 Aug 2020 11:30 AM ISTResearchers at the Washington University School of Medicine in St. Louis have found in a new study that reducing adipose tissue volume, by whatever...
Compression therapy reduces recurrent leg cellulitis, finds NEJM study Dr Satabdi Saha13 Aug 2020 11:45 AM ISTCompression therapy seems to prevent recurrent leg cellulitis better than conservative management, according to a trial in the New England Journal of...
Myomectomy bests uterine artery embolization for treating uterine Fibroids: NEJM study Dr. Kamal Kant Kohli31 July 2020 6:30 AM ISTResearchers have found in a randomized trial that women with symptomatic uterine fibroids reported significantly better quality of life (QoL)...
Severe burning pain in legs after taking migraine medicine: NEJM Case report Dr. Kamal Kant Kohli23 July 2020 8:12 AM ISTDr Aravind Reghukumar at Government Medical College, Thiruvananthapuram, Thiruvananthapuram, India and Dr Reshma Benson have reported a rare case...
Vitamin D supplementation may not lower risk of TB infection finds NEJM study Dr. Kamal Kant Kohli23 July 2020 4:00 AM ISTResearchers have found in a new study that Vitamin D supplementation did not result in a lower risk of tuberculosis infection or tuberculosis disease....
Subcutaneous nemolizumab improves itching in atopic dermatitis patients: NEJM Medha Baranwal19 July 2020 9:00 PM ISTJapan: Subcutaneous nemolizumab plus topical agents versus placebo plus topical agents helps in a greater reduction of itching in patients...
Dexamethasone trial results confirm COVID-19 benefits but also risks Hina Zahid18 July 2020 8:45 AM ISTThe keenly-awaited full results from a UK trial of the steroid dexamethasone were published Friday, confirming its life-saving benefits for COVID-19...
Topical roflumilast improves chronic plaque psoriasis, finds new research Dr. Kamal Kant Kohli18 July 2020 7:00 AM ISTResearchers at the Icahn School of Medicine report that roflumilast cream (ARQ-151), which contains a highly potent, selective phosphodiesterase-4...
Newly discovered PRIME cells may predict rheumatoid arthritis flares: NEJM Study Dr. Kamal Kant Kohli17 July 2020 6:00 PM ISTRheumatoid arthritis, like many inflammatory diseases, is characterized by episodes of quiescence and exacerbation (flares). During symptoms flare up,...
